Range Financial Group’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$366K Sell
26,707
-1,745
-6% -$23.8K 0.1% 168
2026
Q2
$385K Sell
28,452
-2,294
-7% -$27.4K 0.11% 166
2026
Q1
$184K Buy
30,746
+4,767
+18% +$35.9K 0.06% 188
2025
Q4
$186K Sell
25,979
-2,109
-8% -$16.7K 0.06% 193
2025
Q3
$300K Buy
+28,088
New +$276K 0.11% 168
2025
Q1
– Sell
-55,435
Closed -$827K – 196
2024
Q4
$827K Buy
+55,435
New +$903K 0.38% 83
2024
Q3
– Sell
-40,433
Closed -$837K – 146
2024
Q2
$837K Buy
40,433
+1,078
+3% +$21.4K 0.43% 76
2024
Q1
$740K Buy
39,355
+27,860
+242% +$478K 0.38% 86
2023
Q4
$166K Buy
+11,495
New +$156K 0.1% 159

Other funds holding OGN

Range Financial Group's OGN Position: Q3 2026 in Review

Range Financial Group reduced its Organon & Co (OGN) stake by 6.1% in Q3 2026, selling an estimated $23.8K and leaving 26,707 shares worth $366K. The position accounts for 0.1% of the portfolio, ranked #168.

Range Financial Group first reported a position in OGN in Q4 2023 and has held it in 9 quarters since. The position peaked at $837K in Q2 2024. 90 funds tracked by Wall St. Rank hold OGN as of Q3 2026.

  • Range Financial Group held 26,707 shares of Organon & Co worth $366K as of Q3 2026.
  • Range Financial Group sold 1,745 Organon & Co shares in Q3 2026, an estimated $23.8K.
  • Organon & Co made up 0.1% of Range Financial Group's portfolio in Q3 2026, its #168 holding.
  • Range Financial Group first reported a position in Organon & Co in Q4 2023 and has held it in 9 quarters since.
  • Range Financial Group's Organon & Co position peaked at $837K in Q2 2024.
  • 90 funds tracked by Wall St. Rank held Organon & Co as of Q3 2026.

Based on Range Financial Group's 13F filing for Q3 2026, filed 21 Oct 2026.